Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Wentong Huoxue cream is a Traditional Chinese Medicine (TCM) topical formulation developed by the Xinjiang Uygur Autonomous Region Traditional Chinese Medicine Hospital. It is specifically designed for the treatment of diabetic peripheral neuropathy (DPN), a common complication of type 2 diabetes. The cream is formulated based on the TCM principles of "warming the meridians" (Wentong) and "promoting blood circulation" (Huoxue) to address the underlying pathology of cold-dampness and blood stasis often associated with neuropathic symptoms. By applying the cream topically to affected areas, it aims to improve local microcirculation, alleviate pain and numbness, and potentially enhance nerve conduction velocity. It is currently being evaluated in randomized, double-blind, placebo-controlled clinical trials to establish its efficacy and safety as a non-invasive therapeutic option for DPN.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Wentong Huoxue cream.